Unique Role of the TLR9-MyD88 Signaling Pathway in Dendritic Cells in AAV Capsid-Specific CD8+ T Cell Activation

被引：1
|
作者：
Rogers, Geoffrey L. [1 ]
Zolotukhin, Irene [1 ]
Herzog, Roland W. [1 ]
机构：
[1] Univ Florida, Pediat, Gainesville, FL USA
来源：
MOLECULAR THERAPY | 2015年 / 23卷
关键词：
D O I：
10.1016/S1525-0016(16)34128-4
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
519
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [1] Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells
    Rogers, Geoffrey L.
    Shirley, Jamie L.
    Zolotukhin, Irene
    Kumar, Sandeep R. P.
    Sherman, Alexandra
    Perrin, George Q.
    Hoffman, Brad E.
    Srivastava, Arun
    Basner-Tschakarjan, Etiena
    Wallet, Mark A.
    Terhorst, Cox
    Biswas, Moanaro
    Herzog, Roland W.
    [J]. BLOOD, 2017, 129 (24) : 3184 - 3195
  • [2] TLR9 and Dendritic Cells Are Required for CD8+ T Cell Responses to the AAV Capsid
    Rogers, Geoffrey L.
    Herzog, Roland W.
    [J]. BLOOD, 2014, 124 (21)
  • [3] Identification of mouse AAV capsid-specific CD8+ T cell epitopes
    Sabatino, DE
    Mingozzi, F
    Hui, DJ
    Chen, HF
    Colosi, P
    Ertl, HCJ
    High, KA
    [J]. MOLECULAR THERAPY, 2005, 12 (06) : 1023 - 1033
  • [4] Direct Type I Interferon Signaling in Conventional Dendritic Cells and T Help are Required for Cross-Priming AAV Capsid-Specific CD8+ T Cells
    Shirley, Jamie L.
    Herzog, Roland W.
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 77 - 77
  • [5] Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes
    Li, Hua
    Murphy, Samuel L.
    Giles-Davis, Wynetta
    Edmonson, Shyrie
    Xiang, Zhiquan
    Li, Yan
    Lasaro, Marcio O.
    High, Katherine A.
    Ertl, Hildegund C. J.
    [J]. MOLECULAR THERAPY, 2007, 15 (04) : 792 - 800
  • [6] Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
    Martino, Ashley T.
    Basner-Tschakarjan, Etiena
    Markusic, David M.
    Finn, Jonathan D.
    Hinderer, Christian
    Zhou, Shangzhen
    Ostrov, David A.
    Srivastava, Arun
    Ertl, Hildegund C. J.
    Terhorst, Cox
    High, Katherine A.
    Mingozzi, Federico
    Herzog, Roland W.
    [J]. BLOOD, 2013, 121 (12) : 2224 - 2233
  • [7] The Effect of CpG Sequences on Capsid-Specific CD8+ T Cell Responses to AAV Vector Gene Transfer
    Xiang, ZhiQuan
    Kurupati, Raj K.
    Li, Yan
    Kuranda, Klaudia
    Zhou, Xiangyang
    Mingozzi, Federico
    High, Katherine A.
    Ertl, Hildegund C. J.
    [J]. MOLECULAR THERAPY, 2020, 28 (03) : 771 - 783
  • [8] AAV Capsid-Specific CD8+T Cells and Their Responsiveness to Hepatic AAV Gene Transfer
    Li, Hua
    High, Katherine
    Ertl, Hildegund C. J.
    [J]. MOLECULAR THERAPY, 2009, 17 : S313 - S313
  • [9] An Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8+ T Cells
    Palaschak, Brett
    Marsic, Damien
    Herzog, Roland W.
    Zolotukhin, Sergei
    Markusic, David M.
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2017, 5 : 142 - 152
  • [10] Type I IFN Sensing by cDCs and CD4+ T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8+ T Cells
    Shirley, Jamie L.
    Keeler, Geoffrey D.
    Sherman, Alexandra
    Zolotukhin, Irene
    Markusic, David M.
    Hoffman, Brad E.
    Morel, Laurence M.
    Wallet, Mark A.
    Terhorst, Cox
    Herzog, Roland W.
    [J]. MOLECULAR THERAPY, 2020, 28 (03) : 758 - 770
12345